Levodopa-Entacapone-Carbidopa Intestinal Gel in advanced Parkinson's disease: a single center experience

被引：0
|
作者：
Constantin, V.
Szatmari, S.
Orban-Kis, K.
Bataga, S.
Neagoe, R.
Ciorba, M.
Mihaly, I.
Kelemen, K.
Szasz, J.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1382
引用
收藏
页码：S604 / S605
页数：2
相关论文
共 50 条
  • [41] Opicapone and entacapone as add-on therapy to the treatment of infusions of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease
    Martinez Castrillo, J. C.
    Parees Moreno, I.
    Sanchez Diez, G.
    Alonso Canovas, A.
    MOVEMENT DISORDERS, 2020, 35 : S467 - S467
  • [42] Multicenter study of levodopa carbidopa intestinal gel in Parkinson's disease: the Turkish experience
    Gultekin, Murat
    Ulukan, Cagri
    Tezcan, Sabiha
    Dogu, Okan
    Hanagasi, Hasmet
    Bilgic, Basar
    Bora Tokcaer, Ayse
    Cakmur, Raif
    Elibol, Bulent
    Mirza, Meral
    Ince Gunal, Dilek
    Erer Ozbek, Cigdem Sevda
    Kenangil, Gulay
    Yilmaz Kusbeci, Ozge
    Akbostanci, Muhittin Cenk
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (01) : 66 - 85
  • [43] Initial experience with levodopa intestinal gel for advanced Parkinson's disease
    Cohen, O. S.
    Yahalom, G.
    Strauss, H.
    Faust-Socher, A.
    Lang, A.
    Lerman, S. F.
    Baer, S. Hassin
    MOVEMENT DISORDERS, 2014, 29 : S137 - S137
  • [44] Levodopa-carbidopa intestinal gel via PEG-J for advanced Parkinson's disease- A single centre experience
    Pekkonen, E.
    Lyytinen, J.
    Lindstrom, O.
    Kylanpaa, L.
    Udd, M.
    MOVEMENT DISORDERS, 2016, 31 : S620 - S620
  • [45] Efficacy and safety of levodopa-carbidopa intestinal gel (LCIG) for advanced Parkinson's disease: a Turkish single-centre experience
    Karadag, Y. Sucullu
    MOVEMENT DISORDERS, 2020, 35 : S484 - S484
  • [46] Combined levodopa carbidopa with Entacapone improves the motor complications in advanced Parkinson's disease
    Ali, Md Ashraf
    MOVEMENT DISORDERS, 2016, 31 : S27 - S27
  • [47] TRIPLE COMBINATION OF LEVODOPA, CARBIDOPA AND ENTACAPONE BY INTRAJEJUNAL PUMP IN ADVANCED PARKINSON'S DISEASE
    Bertalan, Gyorfi
    Botond, Balo
    Krisztina, Botz
    Jost, Wolfgang H.
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (11-12): : 365 - 368
  • [48] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [49] Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Udd, Marianne
    Lyytinen, Jukka
    Eerola-Rautio, Johanna
    Kenttamies, Anu
    Lindstrom, Outi
    Kylanpaa, Leena
    Pekkonen, Eero
    BRAIN AND BEHAVIOR, 2017, 7 (07):
  • [50] Titration of Levodopa-Carbidopa Intestinal Gel in US Patients with Advanced Parkinson's Disease
    Aldred, Jason
    Davis, Thomas
    Zamudio, Jorge
    Kukreja, Pavnit
    Bergmann, Lars
    Li, Mei
    Standaert, David
    MOVEMENT DISORDERS, 2018, 33 : S93 - S93
12345